IRIS
FERRO, MATTEO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.174
EU - Europa 552
AS - Asia 550
AF - Africa 40
OC - Oceania 2
Totale 2.318
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.158
SG - Singapore 284
IT - Italia 254
CN - Cina 152
NL - Olanda 97
VN - Vietnam 96
GB - Regno Unito 53
CI - Costa d'Avorio 39
IE - Irlanda 38
DE - Germania 36
FI - Finlandia 28
CA - Canada 16
IN - India 14
SE - Svezia 12
UA - Ucraina 9
FR - Francia 4
AT - Austria 3
BE - Belgio 3
DK - Danimarca 3
LT - Lituania 3
AU - Australia 2
PL - Polonia 2
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
CH - Svizzera 1
CZ - Repubblica Ceca 1
ES - Italia 1
HR - Croazia 1
MA - Marocco 1
MT - Malta 1
NP - Nepal 1
PK - Pakistan 1
TR - Turchia 1
Totale 2.318
Salva come PNG Salva come JPEG
Città #
Singapore 229
Chandler 202
Ashburn 143
Naples 105
Amsterdam 96
Dong Ket 96
Santa Clara 71
Beijing 47
Millbury 44
Enfield 41
Des Moines 36
Princeton 30
Boston 28
Nanjing 27
Lawrence 22
Napoli 18
Ottawa 16
Washington 16
Wilmington 14
Dublin 12
Phoenix 12
Dearborn 10
Frankfurt am Main 10
Casamassima 9
Hebei 9
Dallas 8
Los Angeles 8
Boardman 7
Houston 7
Jiaxing 7
Kronberg 7
Pune 7
Seattle 7
Changsha 6
Jacksonville 6
Lappeenranta 6
Norwalk 6
Shenyang 6
Tianjin 5
Caserta 4
Chengdu 4
Council Bluffs 4
Milan 4
Nanchang 4
Redwood City 4
Rome 4
Siziano 4
Woodbridge 4
Abidjan 3
Cambridge 3
Florence 3
Hefei 3
Marijampolė 3
Munich 3
Pozzuoli 3
Salerno 3
Wuhan 3
Alba 2
Arezzo 2
Augusta 2
Aversa 2
Cardiff 2
Courcelles 2
Fairfield 2
Falls Church 2
Forlì 2
Guangzhou 2
Helsinki 2
Kolkata 2
Locate di Triulzi 2
London 2
New York 2
Osimo 2
Perugia 2
Piana 2
Romainville 2
Rovereto 2
San Cipriano Picentino 2
Springfield 2
Vienna 2
Afragola 1
Agadir 1
Avellino 1
Baku 1
Benevento 1
Bitonto 1
Brno 1
Brussels 1
Buffalo 1
Bungarribee 1
Burgas 1
Castelnuovo Rangone 1
Cinisello Balsamo 1
Edinburgh 1
Fagnano Olona 1
Gragnano 1
Groningen 1
Grumo Nevano 1
Indiana 1
Karachi 1
Totale 1.565
Salva come PNG Salva come JPEG
Nome #
Renal Cell Carcinoma as a Metabolic Disease: An Update on Main Pathways, Potential Biomarkers, and Therapeutic Targets 102
Urotensin II receptor on preoperative biopsy is associated with upstaging and upgrading in prostate cancer 54
Prostate health index vs percent free prostate-specific antigen for prostate cancer detection in men with "gray" prostate-specific antigen levels at first biopsy: Systematic review and meta-analysis 54
Incidence of fatigue and low-dose corticosteroid use in prostate cancer patients receiving systemic treatment: a meta-analysis of randomized controlled trials 54
Epigenetic signature: A new player as predictor of clinically significant prostate cancer (PCa) in patients on active surveillance (AS) 50
Effects of the ErbB1/ErbB2 kinase inhibitor GW2974 on androgen-independent prostate cancer PC-3 cell line growth and NSE, chromogranin A and osteopontin content. 47
Artificial Intelligence and Machine Learning in Prostate Cancer Patient Management-Current Trends and Future Perspectives 46
Long non-coding RNA containing ultraconserved genomic region 8 promotes bladder cancer tumorigenesis 45
Matrix metalloproteinase-2 and -9 in the urine of prostate cancer patients. 44
Association of statin use and oncological outcomes in patients with first diagnosis of T1 high grade non-muscle invasive urothelial bladder cancer: results from a multicentre study 44
Biomarkers in localized prostate cancer 43
Modified glasgow prognostic score is associated with risk of recurrence in bladder cancer patients after radical Cystectomy: A multicenter experience 42
Improving the prediction of pathologic outcomes in patients undergoing radical prostatectomy: the value of prostate cancer antigen 3 (PCA3), prostate health index (phi) and sarcosine 42
Body mass index was associated with upstaging and upgrading in patients with low-risk prostate cancer who met the inclusion criteria for active surveillance 41
Neutrophil, platelets, and eosinophil to lymphocyte ratios predict gleason score upgrading in low-risk prostate cancer patients 40
Activation of the kynurenine pathway predicts poor outcome in patients with clear cell renal cell carcinoma 39
Preoperative insulin-like growth factor-binding protein-3 (IGFBP-3) blood level predicts gleason sum upgrading 38
Soluble interleukin-6 receptor to interleukin-6 (sIL-6R/IL-6) ratio in serum as a predictor of high Gleason sum at radical prostatectomy 38
Low serum total testosterone level as a predictor of upstaging and upgrading in low-risk prostate cancer patients meeting the inclusion criteria for active surveillance 38
Prognostic accuracy of Prostate Health Index and urinary Prostate Cancer Antigen 3 in predicting pathologic features after radical prostatectomy 38
Predicting pathological features at radical prostatectomy in patients with prostate cancer eligible for active surveillance by multiparametric magnetic resonance imaging 38
Disease-specific and general health-related quality of life in newly diagnosed prostate cancer patients: The Pros-IT CNR study 37
Circular RNAs: An emerging type of non-coding RNA and their potential implications in bladder cancer 37
Systemic combining inflammatory score (SCIS): a new score for prediction of oncologic outcomes in patients with high-risk non-muscle-invasive urothelial bladder cancer 37
Optimized Identification of High-Grade Prostate Cancer by Combining Different PSA Molecular Forms and PSA Density in a Deep Learning Model 37
Phase II trial of cisplatin plus prednisone in docetaxel-refractory castration-resistant prostate cancer patients 36
Validation of Neutrophil-to-lymphocyte Ratio in a Multi-institutional Cohort of Patients With T1G3 Non–muscle-invasive Bladder Cancer 36
Peri-Prostatic Adipocyte-Released TGFβ Enhances Prostate Cancer Cell Motility by Upregulation of Connective Tissue Growth Factor 36
Salvage radical prostatectomy after external beam radiation therapy: A systematic review of current approaches 35
New Cross-Talk Layer between Ultraconserved Non-Coding RNAs, MicroRNAs and Polycomb Protein YY1 in Bladder Cancer 34
Periprostatic adipose tissue promotes prostate cancer resistance to docetaxel by paracrine IGF‐1 upregulation of TUBB2B beta‐tubulin isoform 34
Three vs. Four Cycles of Neoadjuvant Chemotherapy for Localized Muscle Invasive Bladder Cancer Undergoing Radical Cystectomy: A Retrospective Multi-Institutional Analysis 34
An increased body mass index is associated with a worse prognosis in patients administered BCG immunotherapy for T1 bladder cancer 33
The emerging role of obesity, diet and lipid metabolism in prostate cancer 32
The evolving role of monoclonal antibodies in the treatment of patients with advanced renal cell carcinoma: a systematic review 32
Multiparametric Magnetic-Resonance to Confirm Eligibility to an Active Surveillance Program for Low-Risk Prostate Cancer: Intermediate Time Results of a Third Referral High Volume Centre Active Surveillance Protocol 32
Predictors of residual T1 high grade on re-transurethral resection in a large multi-institutional cohort of patients with primary T1 high-grade/grade 3 bladder cancer 32
A risk-group classification model in patients with bladder cancer under neoadjuvant cisplatin-based combination chemotherapy 31
SelectMDx and Multiparametric Magnetic Resonance Imaging of the Prostate for Men Undergoing Primary Prostate Biopsy: A Prospective Assessment in a Multi-Institutional Study 31
Paclitaxel in pretreated metastatic penile cancer: final results of a phase 2 study. 29
Type 2 diabetes mellitus predicts worse outcomes in patients with high-grade T1 bladder cancer receiving bacillus Calmette-Guérin after transurethral resection of the bladder tumor 29
Subcellular Localization of uc.8+ as a Prognostic Biomarker in Bladder Cancer Tissue 28
Neutrophil percentage-to-albumin ratio predicts mortality in bladder cancer patients treated with neoadjuvant chemotherapy followed by radical cystectomy 28
The use of 68Ga prostate-specific membrane antigen PET-CT in prostate cancer: diagnostic challenges and therapeutic opportunities 28
Increased Body Mass Index Is a Risk Factor for Poor Clinical Outcomes after Radical Prostatectomy in Men with International Society of Urological Pathology Grade Group 1 Prostate Cancer Diagnosed with Systematic Biopsies 28
New strategy for the identification of prostate cancer: The combination of Proclarix and the prostate health index 27
Immune Checkpoint Inhibitors as a Neoadjuvant/Adjuvant Treatment of Muscle-Invasive Bladder Cancer: A Systematic Review 27
High-Grade T1 on Re-Transurethral Resection after Initial High-Grade T1 Confers Worse Oncological Outcomes: Results of a Multi-Institutional Study 27
Robot-assisted Partial Nephrectomy: 5-yr Oncological Outcomes at a Single European Tertiary Cancer Center 26
Circulating preoperative testosterone level predicts unfavourable disease at radical prostatectomy in men with International Society of Urological Pathology Grade Group 1 prostate cancer diagnosed with systematic biopsies 26
The Impact of Meat Intake on Bladder Cancer Incidence: Is It Really a Relevant Risk? 25
Urinary long noncoding RNAs in nonmuscle-invasive bladder cancer: new architects in cancer prognostic biomarkers 24
Surgical blood loss during holmium laser enucleation of the prostate (HoLEP) is not affected by short-term pretreatment with dutasteride: a double-blind placebo-controlled trial on prostate vascularity 24
The Efficacy of Flogofilm® in the Treatment of Chronic Bacterial Prostatitis as an Adjuvant to Antibiotic Therapy: A Randomized Prospective Trial 21
Patient Selection for Active Surveillance in the Multi-parametric Magnetic Resonance Imaging Era: A Step Forward in a Rapidly Evolving Field 21
Urologic malignancies: advances in the analysis and interpretation of clinical findings 21
Accuracy of the European Association of Urology (EAU) NMIBC 2021 scoring model in predicting progression in a large cohort of HG T1 NMIBC patients treated with BCG 19
Beyond blood biomarkers: the role of SelectMDX in clinically significant prostate cancer identification 18
Circulating tumor cells in bladder cancer: a new horizon of liquid biopsy for precision medicine 18
Which inflammatory marker, between systemic immune-inflammation index and neutrophil to eosinophil ratio, is associated with Peyronie's disease and are there any implications for a better understanding of its mechanisms? 18
Current Management of Urachal Carcinoma: An Evidence-based Guide for Clinical Practice 17
Reliability of Multiparametric Magnetic Resonance Imaging in Patients with a Previous Negative Biopsy: Comparison with Biopsy-Naïve Patients in the Detection of Clinically Significant Prostate Cancer 14
A Neural Network Model Combining [-2]proPSA, freePSA, Total PSA, Cathepsin D, and Thrombospondin-1 Showed Increased Accuracy in the Identification of Clinically Significant Prostate Cancer 14
Advances in Urinary Diversion: From Cutaneous Ureterostomy to Orthotopic Neobladder Reconstruction-A Comprehensive Review 13
Time to progression is the main predictor of survival in patients with high-risk nonmuscle invasive bladder cancer: Results from a machine learning-based analysis of a large multi-institutional database 12
Early and late post-procedural complications in different orthotopic neobladder surgical approaches: A systematic review 12
Predictive clinico-pathological factors to identify BCG, unresponsive patients, after re-resection for T1 high grade non-muscle invasive bladder cancer 12
Comparing cardiovascular adverse events in cancer patients: A meta-analysis of combination therapy with angiogenesis inhibitors and immune checkpoint inhibitors versus angiogenesis inhibitors alone 12
Serum (-2)proPSA/freePSAratio, (-2)proPSA/freePSA density, prostate health index, and prostate health index density as clues to reveal postoperative clinically significant prostate cancer in men with prostate-specific antigen 2-10 ng/mL 11
The relationship between the history of PDE5-inhibitors assumption and melanoma: a systematic review 11
Bladder Cancer and Risk Factors: Data from a Multi-Institutional Long-Term Analysis on Cardiovascular Disease and Cancer Incidence 11
Molecular Imaging Diagnosis of Renal Cancer Using 99mTc-Sestamibi SPECT/CT and Girentuximab PET-CT-Current Evidence and Future Development of Novel Techniques 10
Management of the incidental adrenal mass, continued surveillance versus surgical excision: analysis of US claims data on contemporary socio-demographic predictors and perioperative outcomes 10
Immune Checkpoint Inhibitors in Renal Cell Carcinoma: Molecular Basis and Rationale for Their Use in Clinical Practice 10
The Role of MUC1 in Renal Cell Carcinoma 10
Contemporary trends in the surgical management of urinary incontinence after radical prostatectomy in the United States 9
Artificial intelligence and radiomics in evaluation of kidney lesions: a comprehensive literature review 9
Radiomics in prostate cancer: an up-to-date review 9
Radiogenomics in Renal Cancer Management-Current Evidence and Future Prospects 9
Novel Key Ingredients in Urinary Tract Health-The Role of D-mannose, Chondroitin Sulphate, Hyaluronic Acid, and N-acetylcysteine in Urinary Tract Infections (Uroial PLUS®) 9
The European Network for the Study of Adrenal Tumors Staging System (2015): A United States Validation 8
Emerging Hallmarks of Metabolic Reprogramming in Prostate Cancer 8
Radiotherapy to the Primary Tumor: The First Step of a Tailored Therapy in Metastatic Prostate Cancer 8
Minimally invasive surgical therapies (MISTs) for lower urinary tract symptoms (LUTS): promise or panacea? 8
Advanced Age Impacts Survival After Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma 8
Complement System and the Kidney: Its Role in Renal Diseases, Kidney Transplantation and Renal Cell Carcinoma 7
Micro-RNAs Predict Response to Systemic Treatments in Metastatic Renal Cell Carcinoma Patients: Results from a Systematic Review of the Literature 7
Inguinal lymphadenectomy in penile cancer patients: a comparison between open and video endoscopic approach in a multicenter setting 7
Cancer Stem Cells in Renal Cell Carcinoma: Origins and Biomarkers 6
Unlocking Precision Medicine: Liquid Biopsy Advancements in Renal Cancer Detection and Monitoring 6
Exploring the Multifactorial Landscape of Penile Cancer: A Comprehensive Analysis of Risk Factors 6
Antioxidant treatment for oligoasthenoteratozoospermia and varicocele: a DBPC trial to evaluate the impact of age and body mass index 6
The detection rate for prostate cancer in systematic and targeted prostate biopsy in biopsy-naive patients, according to the localization of the lesion at the mpMRI: A single-center retrospective observational study 6
Artificial Intelligence in the Advanced Diagnosis of Bladder Cancer-Comprehensive Literature Review and Future Advancement 6
Upper Tract Urothelial Cancer: Guideline of Guidelines 6
Urinary Micro-RNAs As Biomarkers of Urological Cancers: A Systematic Review 5
Cellular and Molecular Players in the Tumor Microenvironment of Renal Cell Carcinoma 5
The impact of venous thromboembolism before open or minimally-invasive radical cystectomy in the USA: insurance claims data on perioperative outcomes and healthcare costs 5
Ischemia-Reperfusion Injury in Kidney Transplantation: Mechanisms and Potential Therapeutic Targets 5
Ablative Treatments for Small Renal Masses and Management of Recurrences: A Comprehensive Review 4
Totale 2.456
Salva come PNG Salva come JPEG
Categoria #
all - tutte 13.757
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.757
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202092 0 0 0 0 2 5 19 2 7 21 29 7
2020/2021190 7 1 4 1 6 11 2 1 31 16 5 105
2021/2022338 9 4 2 0 6 3 6 12 30 39 108 119
2022/2023649 54 25 24 19 77 64 4 52 82 171 72 5
2023/2024551 10 75 100 39 29 56 10 72 7 8 90 55
2024/2025466 135 148 21 55 107 0 0 0 0 0 0 0
Totale 2.474